NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in COVID-19 patients Read more
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms Read more
Skin cells from frontotemporal dementia patients may prove useful in revealing disease mechanisms and in biomarker and drug research Read more